# Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)

> **NCT03549663** · NA · UNKNOWN · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 108 (estimated)

## Conditions studied

- Idiopathic Membranous Nephropathy

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT03549663
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-04
- **Primary completion:** 2020-10
- **Final completion:** 2021-10
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2019-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03549663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03549663, "Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03549663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*